RxDoctor Payments DataLook up a doctor →

Aman Gill, MD

Neurology · Kansas City, KSNPI 1497986525

Payments from drug & device makers

$6,066in general payments, 2019–2025

Across 404 payments — averaging $15.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Teva Pharmaceuticals USA, Inc.$501
  • Bristol Myers Squibb$474
  • UCB, Inc.$379
  • Pfizer$348
  • Biogen$308
  • plus $3K from 38 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)138$1,280
Teva Pharmaceuticals USA, Inc.27$501
Bristol Myers Squibb34$474
UCB, Inc.18$379
Pfizer33$348
Biogen17$308
Amgen15$290
Jazz Pharmaceuticals Inc.5$252
Genentech USA, Inc.8$251
Sanofi13$211
Neurocrine Biosciences, Inc.8$168
Vanda Pharmaceuticals Inc.2$157
Novartis9$141
Lilly USA, LLC8$134
Supernus Pharmaceuticals, Inc.7$98
Johnson & Johnson6$96
Biohaven Pharmaceuticals, Inc.4$95
EMD Serono, Inc.6$95
Argenx US, Inc.2$72
Livanova USA, Inc.4$64
Acadia Pharmaceuticals Inc3$56
Amneal Pharmaceuticals LLC4$49
Corium, LLC3$46
Biohaven Pharmaceutical Holding Company Ltd.3$40
Banner Life Sciences, LLC2$40
SK Life Science, Inc.2$40
Axsome Therapeutics, Inc.2$38
Lundbeck LLC2$35
Medtronic2$32
MDD US Operations, LLC2$31
Kyowa Kirin, Inc.2$29
Harmony Biosciences LLC1$26
E.r. Squibb & Sons, L.L.C.1$23
Mallinckrodt Enterprises LLC1$19
Genentech, Inc.1$18
Eisai Inc.1$17
Ipsen Biopharmaceuticals, Inc1$17
ANI Pharmaceuticals, Inc.1$16
Upsher-smith Laboratories LLC1$15
Adamas Pharmaceuticals, Inc.1$14
Neurelis, Inc.1$13
Zyla Life Sciences, Inc.1$13
Acorda Therapeutics, Inc1$13
Mallinckrodt Hospital Products Inc.1$12

How this compares

$6,066 in reported general payments places this provider in the 65th percentile of 131 neurology providers in Kansas.

See all neurology providers in Kansas →

Medicare billing

Part B allowed, 2024
$78,343
Medicare patients
326
Services billed
613

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Kansas City

See the full list for Kansas →

Where these figures come from

Is this you, or does something look wrong? →